Stellenwert der Thrombelastometrie für das Monitoring von Faktor XIII
Sanders, J.-O.; Friedrich, K.; Gerlach, R.; Platz, J.; Miesbach, W.; Hanke, A.-A.; Hofstetter, C.; Weber, C.-F. · Zeitschrift für Orthopädie und Unfallchirurgie · 2011 · Heft 02 · S. 111 bis 117
Bibliografische Angaben
Zusammenfassung
SummaryRecently published studies give evidence, that an increased maximum lysis in the APTEM® – test (ML60 > 12%) of the ROTEM® (Tem International GmbH, Munich, Germany) might indicate a factor XIII deficiency (FXIII < 70%). It was the aim of this study to investigate the feasibility of thrombelastometric measurements with the ROTEM device to reflect the isolated influence of FXIII on clot stability and therefore to indicate potential factor XIII deficiencies. Patients, method: After approval by the local Scientific and Ethic Review Board, 26 consecutive patients, scheduled for elective craniotomy for tumour re…
